Contextual Representation Learning With ResNet Refinement and Deep Classification for Enhanced Drug Target Interaction Prediction

IF 3.3 4区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Essmily Simon, Sanjay Bankapur
{"title":"Contextual Representation Learning With ResNet Refinement and Deep Classification for Enhanced Drug Target Interaction Prediction","authors":"Essmily Simon,&nbsp;Sanjay Bankapur","doi":"10.1111/cbdd.70358","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Accurate prediction of drug target interactions (DTIs) plays a pivotal role in drug discovery and repositioning. However, it remains challenging due to the structural complexity of proteins and small-molecule compounds, along with the limited generalisation capability of existing computational approaches. Drug target interaction prediction is important in computer-aided drug design and drug repurposing, especially for complex diseases where multiple targets are involved. This study aims to develop a robust deep learning framework that enhances DTI prediction accuracy by effectively capturing contextual and biochemical features from both protein and drug representations. Four standard DTI datasets and a combined drug repurposing dataset are used to learn interaction patterns across multiple targets. We propose a novel deep learning framework that leverages pre-trained BERT-based language models to extract contextual embeddings from protein and drug sequences. These modality-specific representations are refined using a proposed dedicated ResNet-based subnetwork to preserve intrinsic biochemical characteristics. The refined embeddings are subsequently integrated and passed through a proposed deep feedforward neural network for final DTI prediction. The proposed model was evaluated on four benchmark datasets, namely DrugBank, <i>Caenorhabditis elegans</i>, BindingDB and GPCR. Experimental results demonstrate consistent performance improvements over baseline methods, including an F1-score gain of ~6.6% on the GPCR dataset and a 3.7% increase in classification accuracy on BindingDB. Stable F1-score improvements were also observed on DrugBank (0.4%) and <i>Caenorhabditis elegans</i> (0.8%). Statistical validation using paired ω-tests at a 5% significance level confirms the improvements are significant. Evaluation on an independent drug repurposing dataset achieved a 6.7% performance gain over existing approaches. The results demonstrate that the proposed framework effectively captures contextual and structural information, leading to improved prediction accuracy and generalisation, highlighting its robustness and practical applicability for drug discovery and drug repurposing.</p>\n </div>","PeriodicalId":143,"journal":{"name":"Chemical Biology & Drug Design","volume":"108 1","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Biology & Drug Design","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cbdd.70358","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Accurate prediction of drug target interactions (DTIs) plays a pivotal role in drug discovery and repositioning. However, it remains challenging due to the structural complexity of proteins and small-molecule compounds, along with the limited generalisation capability of existing computational approaches. Drug target interaction prediction is important in computer-aided drug design and drug repurposing, especially for complex diseases where multiple targets are involved. This study aims to develop a robust deep learning framework that enhances DTI prediction accuracy by effectively capturing contextual and biochemical features from both protein and drug representations. Four standard DTI datasets and a combined drug repurposing dataset are used to learn interaction patterns across multiple targets. We propose a novel deep learning framework that leverages pre-trained BERT-based language models to extract contextual embeddings from protein and drug sequences. These modality-specific representations are refined using a proposed dedicated ResNet-based subnetwork to preserve intrinsic biochemical characteristics. The refined embeddings are subsequently integrated and passed through a proposed deep feedforward neural network for final DTI prediction. The proposed model was evaluated on four benchmark datasets, namely DrugBank, Caenorhabditis elegans, BindingDB and GPCR. Experimental results demonstrate consistent performance improvements over baseline methods, including an F1-score gain of ~6.6% on the GPCR dataset and a 3.7% increase in classification accuracy on BindingDB. Stable F1-score improvements were also observed on DrugBank (0.4%) and Caenorhabditis elegans (0.8%). Statistical validation using paired ω-tests at a 5% significance level confirms the improvements are significant. Evaluation on an independent drug repurposing dataset achieved a 6.7% performance gain over existing approaches. The results demonstrate that the proposed framework effectively captures contextual and structural information, leading to improved prediction accuracy and generalisation, highlighting its robustness and practical applicability for drug discovery and drug repurposing.

基于ResNet细化和深度分类的上下文表示学习用于增强药物靶点相互作用预测
准确预测药物靶标相互作用(DTIs)在药物发现和重新定位中起着关键作用。然而,由于蛋白质和小分子化合物的结构复杂性,以及现有计算方法有限的泛化能力,它仍然具有挑战性。药物靶点相互作用预测在计算机辅助药物设计和药物再利用中具有重要意义,特别是在涉及多个靶点的复杂疾病中。本研究旨在开发一个强大的深度学习框架,通过有效地从蛋白质和药物表征中捕获上下文和生化特征来提高DTI预测的准确性。使用四个标准DTI数据集和一个组合药物再利用数据集来学习跨多个靶点的相互作用模式。我们提出了一种新的深度学习框架,利用预训练的基于bert的语言模型从蛋白质和药物序列中提取上下文嵌入。这些特定于模式的表示使用提议的专用的基于resnet的子网进行细化,以保持内在的生化特征。随后,对精细化的嵌入进行整合,并通过所提出的深度前馈神经网络进行最终的DTI预测。在DrugBank、秀丽隐杆线虫(Caenorhabditis elegans)、BindingDB和GPCR四个基准数据集上对该模型进行了评估。实验结果表明,与基线方法相比,该方法的性能得到了一致的改善,包括GPCR数据集的f1得分提高了约6.6%,BindingDB的分类准确率提高了3.7%。在DrugBank(0.4%)和秀丽隐杆线虫(0.8%)上也观察到稳定的f1评分改善。使用配对ω-检验在5%显著性水平下的统计验证证实了改进是显著的。在独立药物再利用数据集上的评估比现有方法获得了6.7%的性能提升。结果表明,所提出的框架有效地捕获了上下文和结构信息,从而提高了预测的准确性和泛化性,突出了其在药物发现和药物再利用方面的鲁棒性和实用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Chemical Biology & Drug Design
Chemical Biology & Drug Design 医学-生化与分子生物学
CiteScore
5.10
自引率
3.30%
发文量
164
审稿时长
4.4 months
期刊介绍: Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书